And inhibition or depletion of kisspeptin/GPR54 significantly reduced tumor formation by eliminating T cell exhaustion and intensified the antitumor immune responses implying a promising target for T cell mediated immune therapy. This evidence concerns the gene KISS1 and neoplasm.